Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Neonatal Hyperbilirubinemia Learning and Decisionmaking Tool appears, based on the captured page content, to be a learning and decision-support web page for monitoring neonatal jaundice. It asks users to enter the date and time of birth, sex, and information related to hours after birth and risk factors. Strictly by category, it is not a typical developer tool; it is closer to a medical education or clinical decision-support calculation form.
The tool’s main interaction is form-based data entry, including birth date and time down to the minute, male/female sex, and major and minor risk factors. Major risk factors include gestational age of 35 to 37+6/7 weeks, temperature instability, lethargy, hemolytic disease, acidosis, sepsis, asphyxia, albumin below 3.0g/dL, G6PD deficiency, and an ill-appearing newborn. Minor risk factors include breastfeeding, perinatal use of oxytocin/diazepam, Asian or Native American ethnicity, gestational diabetes, and more. This suggests that the tool is designed to help users organize case information by risk factor and support learning or decision-making.
The available text does not show any information about supported languages, frameworks, APIs, SDKs, webhooks, command-line tools, or plugin ecosystems. It also does not state whether the tool is open source, whether self-hosting is allowed, or whether it can integrate with electronic medical records or learning systems. As a result, from a developer-tool perspective, its extensibility and engineering capabilities cannot be confirmed. In terms of documentation, the captured content only presents form fields and risk factors; it does not show guideline references, algorithm explanations, version updates, a privacy policy, or compliance statements, so there is insufficient information to assess documentation quality.
The page content does not disclose pricing, paid plans, an account system, or payment methods, and it is not possible to confirm whether the tool is free. There is no captured evidence regarding accessibility from China, so this remains unknown for now. When using medical web pages in China, users should also consider network accessibility, compatibility with local medical guidelines, and data privacy issues.
Its strengths are a focused use case, intuitive fields, and broad coverage of risk factors. It may be suitable for pediatrics, neonatology, and obstetrics professionals who need to organize hyperbilirubinemia risk information for learning or teaching. Its limitations are the lack of public information, absence of visible medical references, and no developer interface documentation. Its clinical reliability cannot be judged based only on the captured text. If you need mature alternatives, consider comparing it with BiliTool, PediTools bilirubin tools, or calculators based on AAP guidelines.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on neonatalhyperbilirubinemia.org official site.
neonatalhyperbilirubinemia.org is an United States Dev Tools provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach neonatalhyperbilirubinemia.org directly.